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Abstract
AIM: To identify the stochastic autoregressive 
integrated moving average (ARIMA) model for short 
term forecasting of hepatitis C virus (HCV) seropositivity 
among volunteer blood donors in Karachi, Pakistan.
METHODS: Ninety-six months (1998-2005) data on 
HCV seropositive cases (1000-1 × month-1) among male 
volunteer blood donors tested at four major blood 
banks in Karachi, Pakistan were subjected to ARIMA 
modeling. Subsequently, a fitted ARIMA model was 
used to forecast HCV seropositive donors for 91-96 mo 
to contrast with observed series of the same months. 
To assess the forecast accuracy, the mean absolute 
error rate (%) between the observed and predicted 
HCV seroprevalence was calculated. Finally, a fitted 
ARIMA model was used for short-term forecasts 
beyond the observed series.
RESULTS: The goodness-of-fit test of the optimum 
ARIMA (2,1,7) model showed non-s ign i f i cant 
autocorrelations in the residuals of the model. The 
forecasts by ARIMA for 91-96 mo closely followed the 
pattern of observed series for the same months, with 
mean monthly absolute forecast errors (%) over 6 mo 
of 6.5%. The short-term forecasts beyond the observed 
series adequately captured the pattern in the data and 
showed increasing tendency of HCV seropositivity with 
a mean ± SD HCV seroprevalence (1000-1 × month-1) 
of 24.3 ± 1.4 over the forecast interval.
CONCLUSION: To curtail HCV spread, public health 
authorities need to educate communities and health 
care providers about HCV transmission routes based 
on known HCV epidemiology in Pakistan and its 
neighboring countries. Future research may focus on 
factors associated with hyperendemic levels of HCV 
infection.
© 2009 The WJG Press and Baishideng. All rights reserved.
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INTRODUCTION
Hepatitis C virus (HCV) infection poses a major public 
health problem in developing countries, including 
Pakistan. However, the results of  prevalence studies have 
shown variable estimates in select groups including 1.8% 
to 3.0% in volunteer blood donors[1,2] and 16% to 20.5% 
in familial contacts of  infected patients[3,4]. A community-
based study in Hafizabad, Punjab, found a 6.5% HCV 
seroprevalence[5]. Using these estimates, Pakistan has 
been grouped into intermediate category with respect 
to burden of  HCV infection[6]. Several routes have been 
implicated for nosocomial and community acquired 
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HCV infection including unsafe injections, recycling of  
used syringes, inadequate sterilization of  surgical and 
dental equipment, and facial shaving by barbers[2,7].
Public health authorities in Pakistan intermittently 
run educational campaigns in electronic and print media 
to create awareness in the general population to halt 
HCV spread. However, in the absence of  adequate 
HCV surveillance, the true impact of  the HCV control 
efforts remains uncertain. Volunteer blood donors are 
generally considered to be the healthier segment of  any 
community and the proportions of  HCV seropositivity 
among them may be considered to mirror the situation 
in the general population[8]. We have previously reported 
a significant increase in HCV seroprevalence among 
volunteer blood donors over the past several years using 
data from two blood banks[2]. However, there is need to 
expand this HCV surveillance network countrywide to 
obtain more reliable and representative estimates.
Recently, mathematical models have been used to 
project the future HCV prevalence among intravenous 
drug users[9], and its impact on the future development 
of  HCV related morbidity and mortality[10]. Modeling 
and forecasting HCV seropositivity among volunteer 
blood donors in Pakistan, and perhaps in other 
neighboring countries, might provide useful information 
for allocating resources, and re-shaping and planning 
future control activities[11]. This study aimed to develop 
a univariate time series model for HCV seropositivity 
(1000-1 × month-1) among volunteer blood donors 
attending four large blood banks. Specifically, the 
objective of  this study was to identify the stochastic 
autoregressive integrated moving average (ARIMA) 
model for short term forecasting of  HCV seropositivity 
(1000-1 × month-1) among volunteer blood donors in 
Karachi, Pakistan.
MATERIALS AND METHODS
Setting
This study was conducted in Karachi-the largest 
cosmopolitan city and the hub of  economic activity 
of  Pakistan. It has an estimated population of  9.3 
million, accounting for approximately 10% of  the total 
population of  the country. Forty three percent of  the city’
s population is under the age of  15 years. The population 
of  Karachi comprises several ethnic groups defined by 
mother tongue, including predominantly Urdu, Sindhi, 
Punjabi, Pushto, and Balochi. The healthcare facilitates 
for the population include several small and tertiary care 
hospitals, both in the private and public sector. 
Data
Eight-year (1998-2005) data on monthly aggregates of  
number of  donors attending four large blood banks 
(blood bank Ⅰ-Ⅳ) in Karachi were available for this 
study. These blood banks receive blood donations only 
from non-remunerated volunteer blood donors. Blood 
bank Ⅰ is part of  a tertiary care hospital in the private 
sector and receives blood donations as replacements 
from friends and relatives of  inpatients requiring 
blood transfusions. Blood banks Ⅱ-Ⅳ belong to non-
governmental organizations and cater for the needs of  
those in Karachi who need blood transfusions, including 
the patients with leukemia, hemophilia, thalassemia and 
other blood related diseases. Blood banks Ⅱ-Ⅳ also 
receive blood donations from volunteers on an exchange 
basis. Prior to blood donation, each blood donor 
is subjected to screening for known risk factors for 
transfusion transmissible infections. All the blood banks 
follow similar criteria to receive blood donations and 
exclude potential donors who admit known risk factors 
of  transfusion transmissible infections or any medical 
or non-medical condition associated with high risk (e.g. 
use of  narcotic drugs, history of  jaundice in the past 
5 years and recent hospitalization). All four blood banks 
in the study use commercially available enzyme-linked 
immunosorbant assay kits and results are interpreted 
according to the manufacturer’s instructions.
As noted earlier, blood donations between January 
1998 and December 2005 by men aged 18-64 years were 
included in this evaluation. HCV serological results of  
consecutive blood donations from these blood banks 
were available from variable starting dates depending 
on the completed records, to assess the proportions of  
HCV seropositive donors.
Analytic approach
We used methods developed by Box and Jenkins to build 
an ARIMA time series model[12]. This model-building 
process is designed to take advantage of  associations in 
the sequentially lagged relationships that usually exist 
in data collected periodically. The general form of  the 
ARIMA model was 
∆1zt = Φ1 zt - 1 + … + Φp zt - p + at - θ1at - 1 - … - θqat - q
where:
∆1zt = differenced series i.e. zt - zt - 1
zt = set of  possible observations on the time-sequenced 
random variable
at = random shock term at time t
Φ1 … ΦP = autoregressive parameters of  order p
θ1 … θp = moving average parameters of  order q
The series was subjected to Box-Cox transformation[13]. 
The transformed series was then differenced at the non-
seasonal level and mean corrected to induce stationarity. 
Sample autocorrelation and partial autocorrelation 
functions were used to identify the ARIMA model 
of  the appropriate order. Estimates of  the model’s 
parameters were obtained by the maximum likelihood 
method. Diagnostic checking included residual analysis 
and the Akaike Information Criterion was used to 
compare goodness-of-fit among ARIMA models. The 
final model was a result of  several iterations of  the 
identification, estimation, and checking process, and 
met the conventional criteria for the adequacy of  the 
model[14].
Assessment of forecast accuracy
The last 6 observations in the data set were used for 
validation of  the forecast accuracy of  the ARIMA 
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RESULTS
Descriptive analysis
The crude HCV seropositivity (1000-1) among the male 
volunteer blood donors during the study period was 
20.3 (12 792/630 134). The mean prevalence (1000-1 
× month-1) was 18.3 [95% confidence interval (CI): 
16.8-19.9]. There was no statistically significant difference 
in HCV seropositivity (1000-1) across various months 
of  the years (F = 0.201; P = 0.997) (data not shown). 
However, a substantial variation in HCV seroprevalence 
(1000-1) was observed across different calendar years 
(F = 47.895; P < 0.001) (Table 1). The observed and 
transformed series are presented in Figure 1.
ARIMA model
The parameters’ estimates for the optimum ARIMA 
(2 ,1 ,7 ) mode l for the se r i e s o f  month ly HCV 
seropositive donors (1000-1) are shown in Table 2. The 
autocorrelation and partial autocorrelation functions of  
the residuals showed good-fit (Figure 2). The residual 
plots showed small variations around the zero mean. 
None of  these residuals had its magnitude larger than 
twice the standard deviation. Residuals’ autocorrelations 
were not significantly different from zero as a set and 
had constant variance, thus confirming the adequacy of  
the model (Ljung-Box statistic = 20.4; P = 0.433).
The forecasts by the ARIMA (2,1,7) model for 
91-96 mo (June 2005 to December 2005) using the 
model. The fitted ARIMA model was used to forecast 
the HCV seroprevalence (1000-1 × month-1) for 91-96 
mo (June 2005 to December 2005) to contrast with 
the observed series of  the same months. The average 
forecast error at prediction interval of  m months (   ) was 
calculated as: 
(   ) = [   (       -       )/6]1/2
Where        and        denote the observed and forecast val-
ues for month t + m. Finally, the fitted ARIMA model 
was used for short term (January 2006 to June 2006) 
forecasts along with their 95% confidence limits beyond 
the observed series.
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Figure 1  Hepatitis C virus seroprevalence (1000-1 × month-1) among volunteer male blood donors in Karachi, Pakistan 1998-2005. A: Observed data along 
with forecasts; B: Transformed series.
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Table 1  Hepatitis C virus seroprevalence (1000-1 × year-1) 
among male volunteer blood donors at four large blood banks 
in Karachi (1998- 2005)
Yr Mean SD 95% CI for mean Minimum Maximum
   Lower limit Upper limit   
1998 13.8 1.5 12.8 14.7 12 16
1999 16.3 2.2 14.8 17.7 13 21
2000 18.5 2.2 17.1 19.9 15 22
2001 19.8 2.0 18.6 21.1 16 22
2002 19.9 3.0 18.0 21.8 15 26
2003 20.3 3.2 18.2 22.3 16 27
2004 29.3 2.6 27.6 30.9 25 33
2005 24.8 2.1 23.4 26.1 21 27
Total 20.3 5.1 19.3 21.3 12 33
F = 47.9; df = 7, 88; P < 0.001.
www.wjgnet.com
observed series of  months 1-90, closely followed 
the pattern of  observed series for the same months 
(Figure 1), with mean ± SD and maximum monthly 
absolute forecast errors (%) over 6 mo interval being 
6.5% ± 3.4% and 10%, respectively. Furthermore, 
the short term (January 2006 to June 2006) forecasts 
beyond the observed series adequately captured the 
pattern in the data (Figure 1) and showed evidence of  
increasing tendency of  HCV seroprevalence (1000-1 × 
month-1) with the mean ± SD as 24.3 ± 1.4 over the 
forecast interval. 
DISCUSSION
Epidemiological surveillance of  communicable diseases 
is one of  the more traditional public health activities. 
Time series analysis of  surveillance data on prevalence 
and/or incidence of  various infections may be helpful 
in developing hypotheses to explain and anticipate the 
dynamics of  the observed phenomena and subsequently 
in the establishment of  a quality control system and re-
allocation of  resources[15,16]. This method is an ecologic 
approach and takes advantage of  the strong association 
in the sequentially lagged relationship that usually exists 
in the data collected periodically[17].
Dur ing the s tudy pe r iod , the ove ra l l HCV 
seroprevalence (1000-1) in volunteer blood donors was 
20.3, which falls in the range of  14.9 to 38.9 known for 
first time blood donors in other developing countries. 
However, HCV seroprevalence (1000-1) in this study 
was much higher than the 2.1 reported for developed 
countries[18]. The low HCV seroprevalence in resource-
rich countries is attributed to safe blood transfusion, 
whereas, in poor regions of  the world, several million 
people acquire HCV infection each year as a result of  
contaminated transfusions and the re-use of  infected 
medical devices[18,19]. Therefore, public health practices 
adopted by the developed countries need to be strictly 
enforced in less developed countries to break the 
chain of  transmission of  HCV and other blood-borne 
pathogens.
Monitoring of  HCV seropositivity among volunteer 
blood donors may provide clues about the effectiveness 
of  control efforts of  public health authorities and future 
trend of  the proportion of  HCV infected donors in 
Pakistan. In this paper, we used the ARIMA model on 
a time series of  HCV seropositivity (1000-1) collected 
monthly over a period of  96 mo on asymptomatic male 
volunteer blood donors from four major blood banks 
in Karachi. The forecasts made in a prospective manner 
over six months demonstrated increasing tendency of  
HCV seropositivity among the blood donors in this 
cosmopolitan city. Such a predicted increase in HCV 
seropositivity might result from inconsistent and naïve 
HCV control efforts on the part of  public health 
officials in Pakistan. Therapeutic injections in a health-
care setting have consistently been shown as a strong 
risk factor for HCV infection in Pakistan[2,7,20,21], and if  
concerted efforts by the public health authorities are not 
made, might continue to contribute to the increasing 
load of  HCV infection in this and similar settings in the 
region. An increasing trend among first time US blood 
donors of  50 to 59 years of  age from 1995 to 2002 has 
been demonstrated[22]. According to the authors, teenage 
children and young adults in 1960, and 1970s might have 
experimented with drug injection and were infected with 
HCV. These people entered into the 50 to 59 years age 
group during 1995 to 2002. However, in other age groups 
of  donors in the same study and two other studies from 
US[23,24], and from other developed countries (France[25,26] 
and Spain[27]) have shown a decreasing trend of  residual 
risk of  HCV infection in blood donors. According to 
these investigators different factors could have played a 
role in this reduction, for instance, increased awareness 
about the factors associated with increased risk of  
HCV infection, voluntary deferral by potential high risk 
Table 2  Autoregressive integrated moving average model 
(2,1,7) of hepatitis C virus seroprevalence (1000-1 × 
month-1) among male volunteer donors in Karachi, Pakistan, 
(January 1998-December 2005)
Parameters Estimate Standard error t -ratio
Autoregressive parameter (Φ)
   Φ2  0.67 0.15 4.5
Moving average parameter (θ)
   θ2 -0.59 0.18 3.3
   θ3  0.49 0.15 3.3
   θ4 -0.80 0.11 7.3
   θ6  0.74 0.21 3.5
   θ7 -0.37 0.17 2.2
White noise variance = 9.74; Ljung-Box Q statistic = 20.4 (P = 0.433).
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Figure 2  Residual plots for the final ARIMA (2,1,7) model of HCV 
seroprevalence (1000-1 × month-1) among male volunteer blood donors 
in Karachi, Pakistan 1998-2005. A: Autocorrelation function; B: Partial 
autocorrelation function.
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donors, improvement in donor recruitment, and /or an 
overall decrease in HCV infection level in the general 
population. Such factors need to be evaluated in our 
population in future studies.
Results from our previous study[2], and those 
predicted by ARIMA model for 6 mo beyond the 
observed data exhibited a slightly increasing tendency of  
HCV seropositivity among male volunteer blood donors 
over the forecast period. This increasing pattern of  
HCV seroprevalence among these asymptomatic male 
volunteer donors merits further investigation of  factors 
contributing to HCV seroprevalence in this population, 
which is thought to be a mirror image of  the situation in 
the general population.
Some limitations of  this study need to be taken 
into account when interpreting the results. Our HCV 
seroprevalence estimates are based on ELISA, which has 
sensitivity of  more than 95%. However, these results 
do not reflect possible HCV infections that do not 
produce detectable seropositivity during the window 
period of  HCV infection. The exact proportion of  these 
HCV infected, but HCV seronegative, is not known, 
however, it has been argued that this figure must be 
very small given the use of  current sero-assays[28]. Our 
HCV seroprevalence estimates in male volunteer donor 
population were based on data from a limited number of  
blood banks; we do not know whether they reflect the 
national average. The blood banks that participated in 
this study however, account for a substantial proportion 
of  donations made annually in Karachi. These centers 
are located in large metropolitan areas where the 
prevalence and/or incidence of  HCV may be higher than 
the national figures. Therefore, we think we are justified 
in making generalizations from our data. In conclusion, 
in the absence of  comprehensive HCV surveillance in 
the general population in Pakistan and perhaps in other 
neighboring countries, further monitoring of  HCV 
seropositivity in blood donors and the investigation of  
factors associated with hyperendemic HCV infection 
using multivariate ARMIA models might further expand 
our understanding about HCV epidemiology in this 
region. Furthermore, effective screening of  all blood 
donors for HCV infection at all blood banks should be 
seriously considered, because one single HCV infected 
regular blood donor could transmit the infection to 
several recipients. 
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 COMMENTS
Background
Less developed countries such as Pakistan generally lack effective surveillance 
systems for communicable diseases. In this study, the authors used the Box-
Jenkins approach to fit an autoregressive integrated moving average (ARIMA) 
model that might be used to monitor and predict trends in hepatitis C virus (HCV) 
seroprevalence in the general population using volunteer blood donors as a 
sentinel group. This information may be helpful to facilitate early public health 
responses to minimize HCV related morbidity and mortality. 
Research frontiers
Developed countries have been able to control the HCV transmission in the 
general population by public health measures. However, such initiatives are 
practiced at sub-optimal level in resource-constrained countries. This problem is 
further compounded by the absence of effective surveillance of communicable 
diseases including blood-borne pathogens. Therefore, alternative methods 
to monitor and predict the burden of such infections are needed for rational 
allocation of resources.
Innovations and breakthroughs
This is the first application of an ARIMA model to monitor and predict the HCV 
seroprevalence in volunteer blood donors at multiple blood banks. Such data on 
infections with HCV and other blood-borne pathogens may mirror the situation 
in a setting that lacks an effective surveillance system for these infections.
Application
The fitted ARIMA model could be used for sentinel surveillance of blood-borne 
infections in volunteer blood donors. Therefore, the estimates for current and 
predicted future burden of these infections could be used by public health 
authorities for making rational policy decisions for control and prevention of 
HCV and other blood-borne pathogens in resource-constrained countries 
including Pakistan.
Peer review
The authors describe an effective model to predict HCV seropositivity in 
Pakistan.
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